These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 29142138)

  • 41. CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis.
    Rossi D; Volanti P; Brambilla L; Colletti T; Spataro R; La Bella V
    J Neurol; 2018 Mar; 265(3):510-521. PubMed ID: 29322259
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis.
    Verde F; Steinacker P; Weishaupt JH; Kassubek J; Oeckl P; Halbgebauer S; Tumani H; von Arnim CAF; Dorst J; Feneberg E; Mayer B; Müller HP; Gorges M; Rosenbohm A; Volk AE; Silani V; Ludolph AC; Otto M
    J Neurol Neurosurg Psychiatry; 2019 Feb; 90(2):157-164. PubMed ID: 30309882
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inflammation in amyotrophic lateral sclerosis spinal cord and brain is mediated by activated macrophages, mast cells and T cells.
    Graves MC; Fiala M; Dinglasan LA; Liu NQ; Sayre J; Chiappelli F; van Kooten C; Vinters HV
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Dec; 5(4):213-9. PubMed ID: 15799549
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A data-driven approach links microglia to pathology and prognosis in amyotrophic lateral sclerosis.
    Cooper-Knock J; Green C; Altschuler G; Wei W; Bury JJ; Heath PR; Wyles M; Gelsthorpe C; Highley JR; Lorente-Pons A; Beck T; Doyle K; Otero K; Traynor B; Kirby J; Shaw PJ; Hide W
    Acta Neuropathol Commun; 2017 Mar; 5(1):23. PubMed ID: 28302159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI
    Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Total tau is increased, but phosphorylated tau not decreased, in cerebrospinal fluid in amyotrophic lateral sclerosis.
    Wilke C; Deuschle C; Rattay TW; Maetzler W; Synofzik M
    Neurobiol Aging; 2015 Feb; 36(2):1072-4. PubMed ID: 25453560
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of insulin-like growth factor-II and leukemia inhibitory factor antibody immunostaining on the ionized calcium-binding adaptor molecule 1-positive microglias in the spinal cord of amyotrophic lateral sclerosis patients.
    Kihira T; Suzuki A; Kubo T; Miwa H; Kondo T
    Neuropathology; 2007 Jun; 27(3):257-68. PubMed ID: 17645240
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of a multiple biomarker panel for diagnosis of amyotrophic lateral sclerosis.
    Chen X; Chen Y; Wei Q; Ou R; Cao B; Zhao B; Shang HF
    BMC Neurol; 2016 Sep; 16():173. PubMed ID: 27634542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnostic Accuracy of a Combined Analysis of Cerebrospinal Fluid t-PrP, t-tau, p-tau, and Aβ42 in the Differential Diagnosis of Creutzfeldt-Jakob Disease from Alzheimer's Disease with Emphasis on Atypical Disease Variants.
    Abu Rumeileh S; Lattanzio F; Stanzani Maserati M; Rizzi R; Capellari S; Parchi P
    J Alzheimers Dis; 2017; 55(4):1471-1480. PubMed ID: 27886009
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnostic and Prognostic Role of Blood and Cerebrospinal Fluid and Blood Neurofilaments in Amyotrophic Lateral Sclerosis: A Review of the Literature.
    Gagliardi D; Meneri M; Saccomanno D; Bresolin N; Comi GP; Corti S
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discriminative and prognostic potential of cerebrospinal fluid phosphoTau/tau ratio and neurofilaments for frontotemporal dementia subtypes.
    Pijnenburg YA; Verwey NA; van der Flier WM; Scheltens P; Teunissen CE
    Alzheimers Dement (Amst); 2015 Dec; 1(4):505-12. PubMed ID: 27239528
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches.
    Wilke C; Pujol-Calderón F; Barro C; Stransky E; Blennow K; Michalak Z; Deuschle C; Jeromin A; Zetterberg H; Schüle R; Höglund K; Kuhle J; Synofzik M
    Clin Chem Lab Med; 2019 Sep; 57(10):1556-1564. PubMed ID: 31251725
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Profiling TREM2 expression in amyotrophic lateral sclerosis.
    Jericó I; Vicuña-Urriza J; Blanco-Luquin I; Macias M; Martinez-Merino L; Roldán M; Rojas-Garcia R; Pagola-Lorz I; Carbayo A; De Luna N; Zelaya V; Mendioroz M
    Brain Behav Immun; 2023 Mar; 109():117-126. PubMed ID: 36681358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Auto-antibodies against proteins of spinal cord cells in cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS).
    Niebroj-Dobosz I; Dziewulska D; Janik P
    Folia Neuropathol; 2006; 44(3):191-6. PubMed ID: 17039414
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
    Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Soluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosis.
    Steinacker P; Fang L; Kuhle J; Petzold A; Tumani H; Ludolph AC; Otto M; Brettschneider J
    PLoS One; 2011; 6(8):e23600. PubMed ID: 21858182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cerebrospinal fluid erythropoietin (EPO) in amyotrophic lateral sclerosis.
    Brettschneider J; Widl K; Schattauer D; Ludolph AC; Tumani H
    Neurosci Lett; 2007 Apr; 416(3):257-60. PubMed ID: 17368721
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CSF SerpinA1 in Creutzfeldt-Jakob disease and frontotemporal lobar degeneration.
    Abu-Rumeileh S; Halbgebauer S; Steinacker P; Anderl-Straub S; Polischi B; Ludolph AC; Capellari S; Parchi P; Otto M
    Ann Clin Transl Neurol; 2020 Feb; 7(2):191-199. PubMed ID: 31957347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis.
    Brettschneider J; Libon DJ; Toledo JB; Xie SX; McCluskey L; Elman L; Geser F; Lee VM; Grossman M; Trojanowski JQ
    Acta Neuropathol; 2012 Mar; 123(3):395-407. PubMed ID: 22210083
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
    Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H
    Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.